| [1] |
2012 G. IARC[C]//globocan．Lyon,France, 2013: 12-4.
|
| [2] |
张敏璐, 黄哲宙, 郑莹. 中国2008年女性乳腺癌发病、死亡和患病情况的估计及预测[J]. 中华流行病学杂志, 2012, 33(10): 1049-51.
|
| [3] |
Satija A, Ahmed SM, Gupta R, et al. Breast Cancer pain management- A review of current & novel therapies[J]. Indian J Med Res, 2014, 139(2): 216-25.
|
| [4] |
Zagon IS, Mclaughlin PJ, Goodman SR, et al. Opioid receptors and endogenous opioids in diverse human and animal cancers[J]. J Natl Cancer Inst, 1987, 79(5): 1059-65.
|
| [5] |
Schreiber G, Campa MJ, Prabhakar S, et al. Molecular characterization of the human delta opioid receptor in lung Cancer[J]. Anticancer Res, 1998, 18(3A): 1787-92.
|
| [6] |
Scopsi L, Balslev E, Brunner N, et al. Immunoreactive opioid peptides in human breast Cancer[J]. Am J Pathol, 1989, 134(2): 473-9.
|
| [7] |
Gach K, Piestrzeniewicz M, Fichna J, et al. Opioid antagonist-induced regulation of the mu-opioid receptor expression in MCF-7 breast Cancer cell line[J]. Endocr Regul, 2009, 43(1): 23-8.
|
| [8] |
Gach K, Piestrzeniewicz M, Fichna JA, et al. Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast Cancer cell line[J]. Biochem Cell Biol, 2008, 86(3): 217-26. doi: 10.1139/O08-001
|
| [9] |
Mclaughlin PJ, Zagon IS. Novel treatment for triple-negative breast and ovarian Cancer: endogenous opioid suppression of women's cancers[J]. Expert Rev Anticancer Ther, 2014, 14(3): 247-50. doi: 10.1586/14737140.2014.867234
|
| [10] |
Zagon IS, Porterfield NK, Mclaughlin PJ. Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast Cancer[J]. Exp Biol Med (Maywood), 2013, 238 (6): 589-99. doi: 10.1177/1535370213489492
|
| [11] |
Hatzoglou A, Bakogeorgou E, Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast Cancer cell line,is partially mediated through opioid receptors[J]. Eur J Pharmacol, 1996, 296(2): 199-207. doi: 10.1016/0014-2999(95)00703-2
|
| [12] |
Afsharimani B, Baran JA, Watanabe SA, et al. Morphine and breast tumor metastasis: the role of matrix-degrading enzymes[J]. Clin Exp Metastasis, 2014, 31(2): 149-58. doi: 10.1007/s10585-013-9616-3
|
| [13] |
Doornebal CW, Vrijland K, Hau CS, et al. Morphine does not facilitate breast Cancer progression in two preclinical mouse models for invasive lobular and HER2+breast Cancer[J]. Pain, 2015(7): 85-8.
|
| [14] |
Ustun F, Durmus-Altun G, Altaner S, et al. Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC [J]. Med Oncol, 2011, 28(4): 1264-72. doi: 10.1007/s12032-010-9573-5
|
| [15] |
Ecimovic P, Murray D, Doran P, et al. Direct effect of morphine on breast Cancer cell function in vitro: role of the NET1 gene[J]. Br J Anaesth, 2011, 107(6): 916-23. doi: 10.1093/bja/aer259
|
| [16] |
Nguyen J, Luk K, Vang D, et al. Morphine stimulates Cancer progression and mast cell activation and impairs survival in transgenic mice with breast Cancer[J]. Br J Anaesth, 2014, 113(1, SI): 4-13. doi: 10.1093/bja/aeu013
|
| [17] |
Niu DG, Peng F, Zhang W, et al. Morphine promotes Cancer stem cell properties, contributing to chemoresistance in breast Cancer[J]. Oncotarget, 2015, 6(6): 3963-76. doi: 10.18632/oncotarget
|
| [18] |
Chou W, Wang C, Liu P, et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy[J]. Anesthesiology, 2006, 105(2): 334-7. doi: 10.1097/00000542-200608000-00016
|
| [19] |
De Gregori M, Diatchenko L, Belfer I, et al. OPRM1 receptor as new biomarker to help the prediction of post mastectomy pain and recurrence in breast cance[J]. Minerva Anestesiol, 2014(3): 63-5.
|
| [20] |
Bortsov AV, Millikan RC, Belfer IA, et al. mu-Opioid receptor gene a118G polymorphism predicts survival in patients with breast Cancer[J]. Anesthesiology, 2012, 116(4): 896-902. doi: 10.1097/ALN.0b013e31824b96a1
|
| [21] |
Cieslinska A, Sienkiewicz-Szlapka E, Kostyra E, et al. mu-Opioid receptor gene(OPRM1)polymorphism in patients with breast Cancer [J]. Tumour Biol, 2015(11): 125-7.
|
| [22] |
Tan EC, Tan CH, Karupathivan U, et al. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations[J]. Neuroreport, 2003, 14(4): 569-72. doi: 10.1097/00001756-200303240-00008
|
| [23] |
Smith JP, Bingaman SI, Mauger DT, et al. Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic Cancer[J]. Open Access J Clin Trials, 2010(2): 37-48
|
点击查看大图
下载:
